![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 13, 2015 1:49:02 PM
The PR on dCellVax progress was that it would need similar safety trials before approval, of which we have heard zilch.
So now they hire someone else a $13,500/month or almost 20x the rate they do research. Wow, that's going to help. Well, it will help if he can raise enough funds to cover his own salary plus some money to do the experiments they need to get any green light to proceed.
I wasted my time and money on this stock over the past 2 years.
Buyers beware. Until something concrete is released (and we've had nothing in the past 5 months) as to real progress, this is going nowhere but down.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM